STAT3 and esophageal squamous cell carcinoma: These findings in the progression of ESCC disease indicate that STAT3 negatively regulates LHPP expression by binding to its promoter region, suggesting a significant transcriptional inhibitory role that contributes to the pathophysiology of the disease.